insulin glargine
RxNorm concept 274783, ingredient (in).
- RxCUI
- 274783
- Term type
- Ingredient (IN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/274783 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- Lantus (BN, has tradename)
- Toujeo (BN, has tradename)
- Basaglar (BN, has tradename)
- Soliqua (BN, has tradename)
- Semglee (BN, has tradename)
- Rezvoglar (BN, has tradename)
- Langlara (BN, has tradename)
- insulin glargine 100 UNT/ML (SCDC, ingredient of)
- insulin glargine Injectable Solution (SCDF, ingredient of)
- insulin glargine Injectable Product (SCDG, ingredient of)
- insulin glargine 300 UNT/ML (SCDC, ingredient of)
- insulin glargine Pen Injector (SCDF, ingredient of)
- insulin glargine / lixisenatide Injectable Product (SCDG, ingredient of)
- insulin glargine / lixisenatide Pen Injector (SCDF, ingredient of)
- insulin glargine-yfgn 100 UNT/ML (SCDC, ingredient of)
- insulin glargine-aglr 100 UNT/ML (SCDC, ingredient of)
- insulin glargine-aldy 100 UNT/ML (SCDC, ingredient of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 274783 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/274783 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 274783. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.